Your browser doesn't support javascript.
loading
Development of a risk prediction model for postpartum onset of type 2 diabetes mellitus, following gestational diabetes; the lifestyle InterVention in gestational diabetes (LIVING) study.
Belsti, Yitayeh; Moran, Lisa J; Goldstein, Rebecca; Mousa, Aya; Cooray, Shamil D; Baker, Susanne; Gupta, Yashdeep; Patel, Anushka; Tandon, Nikhil; Ajanthan, Saumiyah; John, Renu; Naheed, Aliya; Chakma, Nantu; Lakshmi, Josyula K; Zoungas, Sophia; Billot, Laurent; Desai, Ankush; Bhatla, Neerja; Prabhakaran, Dorairaj; Gupta, Ishita; de Silva, H Asita; Kapoor, Deksha; Praveen, Devarsetty; Farzana, Noshin; Enticott, Joanne; Teede, Helena.
Afiliação
  • Belsti Y; Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
  • Moran LJ; Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
  • Goldstein R; Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Monash Health, Melbourne, Australia.
  • Mousa A; Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
  • Cooray SD; Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Monash Health, Melbourne, Australia.
  • Baker S; Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
  • Gupta Y; All India Institute of Medical Sciences, New Delhi, India.
  • Patel A; The George Institute for Global Health, University of New South Wales, Newtown, NSW, Australia.
  • Tandon N; All India Institute of Medical Sciences, New Delhi, India.
  • Ajanthan S; RemediumOne, Colombo, Sri Lanka.
  • John R; The George Institute for Global Health, New Delhi, India.
  • Naheed A; Non-Communicable Diseases, Nutrition Research Division, International Centre for Diarrhoeal Disease Research, Bangladesh.
  • Chakma N; Non-Communicable Diseases, Nutrition Research Division, International Centre for Diarrhoeal Disease Research, Bangladesh.
  • Lakshmi JK; Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India; The George Institute for Global Health, New Delhi, India; Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
  • Zoungas S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Billot L; The George Institute for Global Health, New Delhi, India; Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
  • Desai A; Department of Endocrinology, Goa Medical College, Goa, India.
  • Bhatla N; All India Institute of Medical Sciences, New Delhi, India.
  • Prabhakaran D; Centre for Chronic Disease Control, New Delhi, India.
  • Gupta I; Centre for Chronic Disease Control, New Delhi, India.
  • de Silva HA; Clinical Trials Unit, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
  • Kapoor D; All India Institute of Medical Sciences, New Delhi, India.
  • Praveen D; Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India; Faculty of Medicine and Health, University of New South Wales, Sydney, Australia; George Institute for Global Health, Hyderabad, India.
  • Farzana N; Non-Communicable Diseases, Nutrition Research Division, International Centre for Diarrhoeal Disease Research, Bangladesh.
  • Enticott J; Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. Electronic address: joanne.enticott@monash.edu.
  • Teede H; Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Monash Health, Melbourne, Australia.
Clin Nutr ; 43(8): 1728-1735, 2024 Jun 08.
Article em En | MEDLINE | ID: mdl-38909514
ABSTRACT

AIMS:

This study aimed to develop a prediction model for identifying a woman with gestational diabetes mellitus (GDM) at high risk of type 2 diabetes (T2DM) post-birth.

METHODS:

Utilising data from 1299 women in the Lifestyle Intervention IN Gestational Diabetes (LIVING) study, two models were developed one for pregnancy and another for postpartum. Key predictors included glucose test results, medical history, and biometric indicators.

RESULTS:

Of the initial cohort, 124 women developed T2DM within three years. The study identified seven predictors for the antenatal T2DM risk prediction model and four for the postnatal one. The models demonstrated good to excellent predictive ability, with Area under the ROC Curve (AUC) values of 0.76 (95% CI 0.72 to 0.80) and 0.85 (95% CI 0.81 to 0.88) for the antenatal and postnatal models, respectively. Both models underwent rigorous validation, showing minimal optimism in predictive capability. Antenatal model, considering the Youden index optimal cut-off point of 0.096, sensitivity, specificity, and accuracy were measured as 70.97%, 70.81%, and 70.82%, respectively. For the postnatal model, considering the cut-off point 0.086, sensitivity, specificity, and accuracy were measured as 81.40%, 75.60%, and 76.10%, respectively.

CONCLUSIONS:

These models are effective for predicting T2DM risk in women with GDM, although external validation is recommended before widespread application.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália